Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B

NCT04850950 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B
Mother-to-Child Transmission
Safety
Efficacy
Hepatitis B Virus
Tenofovir Alafenamide Fumarate

Interventions

DRUG: Tenofovir Alafenamide fumarate 25mg Oral Tablet

Sponsor

The First Affiliated Hospital of Zhengzhou University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]